- Monday - Thurs 8:00 A.M. – 7:30 P.M.
- Friday8:00 A.M. – 6:30 P.M.
- Saturday9:00 A.M. – 12:00 P.M.
Welcome to Save Minds at Smart Clinics
London's Ketamine Treatment Center for Depression, Anxiety, and PTSD.
Call: 020 7052 0070
What Is Ketamine?
Ketamine in an anesthetic developed in the early 1960’s. It is one of the most widely used drugs in modern medicine, and is on the World Health Organization’s List of Essential Medicines. It has a variety of medical uses and is FDA-approved as an anesthetic.
Ketamine has a remarkably safe track record in surgical settings and is frequently used in pediatric surgery. It is also commonly used to treat the extreme physical pain of a condition called CRPS/RSD. Ketamine is also used in veterinary medicine.
A SIMPLE PROCESS
How Does Ketamine Therapy Work?
Ketamine infusion for depression works differently when compared to most other medications such as benzodiazepines; the anti-anxiety feeling it gives the patient wears off as the medicine is consumed in their system. Ketamine infusion, on the other hand, enables the regrowth of brain connections in the patient’s cortex by triggering reactions. As such, the body’s reaction to Ketamine, not its presence, constitutes its effects.
For a patient to be considered for our Ketamine infusion for depression services, there are three criteria for treatment, namely the patient has
- Experienced recurrent suicidal thoughts
- Difficulty managing their depression for an extended period of time
- Treatment-Resistant Depression
The staff at Save Minds is wonderful, attentive and truly care for their patients. My experience was excellent; the treatment was more beneficial than I dared hope. I highly recommend it.
Read Our Latest Articles
Start Feeling Better Today
Our clinics provide patients with paid-for ketamine infusion for depression services – these are particularly helpful for those patients that suffer depression and have also resisted other types of treatments administered to them by either a psychiatrist or a GP. In essence, the service is intended to tackle depression that is non-responsive to Selective Serotonin Reuptake Inhibitors (‘SSRIs’) or other care plans for patients with severe depression. With more than 300 million people globally suffering some sort of depression, it is by far the leading mental disorder condition.